je.st
news
Tag: holdings
Should Endowments Divest Their Holdings in Fossil Fuels?
2014-11-24 10:00:00| Climate Ark Climate Change & Global Warming Newsfeed
Wall Street Journal: College and university endowments have roughly $22 billion, or 5% of their assets, invested in energy and natural resources, according to the National Association of College and University Business Officers. Traditional fossil-fuel investments account for a big chunk of those energy bets, which has sparked a showdown between student activists who say it is morally wrong to support an industry contributing to global climate change, and colleges and universities under pressure to raise funds for...
Tags: holdings
fossil
fuels
divest
DOUTOR NICHIRES Holdings Co. Ltd. - Company Capsule
2014-11-23 01:00:00| Beverage industry market research - from just-drinks.com
Canadean's "DOUTOR NICHIRES Holdings Co. Ltd. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major
Tags: company
holdings
capsule
Zacks' Bull Of The Day: Hawaiian Holdings
2014-11-21 12:07:19| Airlines - Topix.net
This sent the stock to a Zacks Rank #1 . Like many airlines this year, shares of Hawaiian Holdings have soared this year.
Tags: day
bull
holdings
hawaiian
Post Holdings Q4 Earnings Preview: What Should Investors Expect?
2014-11-19 00:57:34| Agriculture - Topix.net
With the fourth-quarter's earnings release expected any day, what should investors expect? Let's take a closer look at where things stand. Stiritz's acquisitions yet to lead to market-beating results Stiritz was profiled in the book The Outsiders and lauded for his execution while running Ralston-Purina.
Tags: post
expect
preview
investors
Bio-Path Holdings Reports Third Quarter 2014 Operational and Financial Results
2014-11-18 11:35:59| Semiconductors - Topix.net
Bio-Path Holdings, Inc., , a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the third quarter ended September 30, 2014. The final patient of cohort six completed treatment in the Phase I clinical trial evaluating Bio-Path's lead product candidate, BP-100-1.01 in blood cancers.
Tags: results
reports
financial
quarter
Sites : [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] next »